Table 2 on page 35 found in COVID-19 Living Evidence Synthesis 10.16 - What is the long-term effectiveness of available COVID-19 vaccines for adults, including for variants of concern and over time frames beyond 112 days in those with a primary series and beyond 84 days in thos

Bacon SL, R., 2023. COVID-19 Living Evidence Synthesis 10.16 - What is the long-term effectiveness of available COVID-19 vaccines for adults, including for variants of concern and over time frames beyond 112 days in those with a primary series and beyond 84 days in thos, McMaster Health Forum. Canada Retrieved from https://canadacommons.ca/artifacts/3746018/covid-19-living-evidence-synthesis-1016/4551946/fragments/2191852/ on 08 May 2024. CID: 20.500.12592/f3944t.

Download citation (RIS)

Table 2 on page 35

Found in: COVID-19 Living Evidence Synthesis 10.16 - What is the long-term …